Results
|
2821.
|
|
|
2822.
|
An enzyme-linked immunosorbent poly(ADP-ribose) polymerase biomarker assay for clinical trials of PARP inhibitors. [electronic resource] by
- Liu, Xuesong
- Palma, Joann
- Kinders, Robert
- Shi, Yan
- Donawho, Cherrie
- Ellis, Paul A
- Rodriguez, Luis E
- Colon-Lopez, Milagros
- Saltarelli, Mary
- LeBlond, David
- Lin, C Thomas
- Frost, David J
- Luo, Yan
- Giranda, Vincent L
Producer: 20081028
In:
Analytical biochemistry vol. 381
Availability: No items available.
|
|
2823.
|
|
|
2824.
|
|
|
2825.
|
|
|
2826.
|
|
|
2827.
|
|
|
2828.
|
Limited margins using modern radiotherapy techniques does not increase marginal failure rate of glioblastoma. [electronic resource] by
- Paulsson, Anna K
- McMullen, Kevin P
- Peiffer, Ann M
- Hinson, William H
- Kearns, William T
- Johnson, Annette J
- Lesser, Glenn J
- Ellis, Thomas L
- Tatter, Stephen B
- Debinski, Waldemar
- Shaw, Edward G
- Chan, Michael D
Producer: 20150501
In:
American journal of clinical oncology vol. 37
Availability: No items available.
|
|
2829.
|
A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation. [electronic resource] by
- Plummer, Ruth
- Lorigan, Paul
- Steven, Neil
- Scott, Lucy
- Middleton, Mark R
- Wilson, Richard H
- Mulligan, Evan
- Curtin, Nicola
- Wang, Diane
- Dewji, Raz
- Abbattista, Antonello
- Gallo, Jorge
- Calvert, Hilary
Producer: 20130620
In:
Cancer chemotherapy and pharmacology vol. 71
Availability: No items available.
|
|
2830.
|
|
|
2831.
|
Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boost. [electronic resource] by
- Ken, Soléakhéna
- Vieillevigne, Laure
- Franceries, Xavier
- Simon, Luc
- Supper, Caroline
- Lotterie, Jean-Albert
- Filleron, Thomas
- Lubrano, Vincent
- Berry, Isabelle
- Cassol, Emmanuelle
- Delannes, Martine
- Celsis, Pierre
- Cohen-Jonathan, Elizabeth Moyal
- Laprie, Anne
Producer: 20130716
In:
Radiation oncology (London, England) vol. 8
Availability: No items available.
|
|
2832.
|
|
|
2833.
|
|
|
2834.
|
|
|
2835.
|
|
|
2836.
|
|
|
2837.
|
|
|
2838.
|
The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma. [electronic resource] by
- Vredenburgh, James J
- Desjardins, Annick
- Reardon, David A
- Peters, Katherine B
- Herndon, James E
- Marcello, Jennifer
- Kirkpatrick, John P
- Sampson, John H
- Bailey, Leighann
- Threatt, Stevie
- Friedman, Allan H
- Bigner, Darell D
- Friedman, Henry S
Producer: 20111017
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 17
Availability: No items available.
|
|
2839.
|
|
|
2840.
|
|